331080007: Mometasone furoate monohydrate 0.05% aqueous nasal spray (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

468290012 Mometasone furoate monohydrate 0.05% aqueous nasal spray en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
721104016 Mometasone furoate monohydrate 0.05% aqueous nasal spray (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1192381014 Mometasone furoate monohydrate 0.05% aqueous nasal spray (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2476625018 Mometasone furoate monohydrate 50mcg spray en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3546861000005115 mometasonfuroatmonohydrat 0,05 % vandig næsespray da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
mometasonfuroatmonohydrat 0,05 % vandig næsespray	Is a	Product containing mometasone (medicinal product)	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	Is a	mometasonfuroatmonohydrat	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Mometasone furoate (substance)	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Mometasone furoate monohydrate (substance)	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Corticosterone	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	binyrehormonmiddel	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	Is a	Mometasone-containing product in nasal dose form	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	Has manufactured dose form	Nasal dose form (dose form)	false	Inferred relationship	Some
mometasonfuroatmonohydrat 0,05 % vandig næsespray	Has manufactured dose form	Nasal spray	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)